ASCO's Richard Schilsky On State-of-the-Art Oncology Trials

 
• By Emily Hayes

ASCO's chief medical officer Richard Schilsky discusses innovative clinical trial designs in oncology, challenges facing developers of cancer combination therapies and future developments for the society's value frameworks.

Umbrellas
Schilsky on the advantages of innovative cancer trials, including umbrella and basket studies • Source: Shutterstock

More from Clinical Trials

More from R&D